Julissa Viana
Vice President of Corporate Communications, Investor Relations, and Patient Advocacy, Veristem Oncology
Replay available
Verastem, Inc. (NASDAQ: VSTM) Q4 2025 earnings conference call, held 2026-03-04. Replay captured from the company's public earnings webcast.

Vice President of Corporate Communications, Investor Relations, and Patient Advocacy, Veristem Oncology
President and Chief Executive Officer, Veristem Oncology
Chief Commercial Officer, Veristem Oncology
President of Development, Veristem Oncology
Chief Financial Officer, Veristem Oncology
Analyst, Kantor
Analyst, Guggenheim Partners
Analyst, Mizuho Securities
Watch the replay and follow the connected company analysis, news, and investor updates for Verastem, Inc..
WEBVTT 00:00:00.031 -- 00:00:05.598 Good afternoon and welcome to Veristem Oncology's fourth quarter and full year 2025 earnings 00:00:05.598 -- 00:00:10.403 conference call. My name is Desiree and I will be your call operator today. 00:00:10.403 -- 00:00:15.430 Please note this event is being recorded. All participants will be in a listen-only 00:00:15.430 -- 00:00:21.357 mode. After today's presentation, there will be an opportunity to ask questions. 00:00:21.357 -- 00:00:26.343 I will now turn the call over to Julissa Viana, Vice President of Corporate Communications, 00:00:26.343 -- 00:00:30.322 Investor Relations, and Patient Advocacy at Veristem Oncology. 00:00:30.322 -- 00:00:33.063 Please go ahead. 00:00:34.066 -- 00:00:38.631 Thank you, operator. Welcome, everyone, and thank you for joining us today to discuss 00:00:38.631 -- 00:00:43.716 Verisim's fourth quarter and full year 2025 financial results and recent 00:00:43.716 -- 00:00:45.638 business updates. 00:00:45.638 -- 00:00:49.943 This afternoon, we issued a press release detailing these results, along with a slide 00:00:49.943 -- 00:00:52.286 presentation that we will reference during our call today. 00:00:52.286 -- 00:00:57.558 Both are available on the investor relations section of our website. 00:00:57.558 -- 00:01:01.805 Before we begin, let me point out that we'll be making forward-looking statements that 00:01:01.805 -- 00:01:04.589 are based on our current expectations and beliefs. 00:01:04.589 -- 00:01:08.876 These statements are subject to certain risks and uncertainties, and actual results may 00:01:08.876 -- 00:01:10.759 differ materially. 00:01:10.759 -- 00:01:15.026 We encourage you to consult the risk factors discussed in our SEC filings for additional 00:01:15.026 -- 00:01:16.468 detail. ...